APA (7th ed.) Citation

Y, W., S, L., W, Z., T, C., B, L., T, P., . . . P, W. (2023). Genomic analysis of cervical carcinoma identifies Alpelisib as a therapeutic option for PIK3CA-mutant cervical carcinoma via the PI3K/AKT pathway. Journal of medical virology, 95(3), e28656. https://doi.org/10.1002/jmv.28656

Chicago Style (17th ed.) Citation

Y, Wei, et al. "Genomic Analysis of Cervical Carcinoma Identifies Alpelisib as a Therapeutic Option for PIK3CA-mutant Cervical Carcinoma via the PI3K/AKT Pathway." Journal of Medical Virology 95, no. 3 (2023): e28656. https://doi.org/10.1002/jmv.28656.

MLA (9th ed.) Citation

Y, Wei, et al. "Genomic Analysis of Cervical Carcinoma Identifies Alpelisib as a Therapeutic Option for PIK3CA-mutant Cervical Carcinoma via the PI3K/AKT Pathway." Journal of Medical Virology, vol. 95, no. 3, 2023, p. e28656, https://doi.org/10.1002/jmv.28656.